Pritesh Kumar, PhD Engaged as Chief Scientific Officer by PharmaCielo Ltd.
TORONTO, Oct. 14, 2016 /CNW/ - PharmaCielo Ltd. is pleased to announce that Dr. Pritesh Kumar has accepted appointment to the position of Chief Scientific Officer for the company, effective immediately. Dr. Kumar is a research scientist with a specialization in cannabinoid pharmacology and will be responsible for leading PharmaCielo's research activities and partnerships globally.